Ketamine, primarily known as an anesthetic and increasingly used for treatment-resistant depression, is a controlled substance. Whether this substance is detectable through standard drug screening methods is a common inquiry, particularly for individuals undergoing medical treatment or involved in legal proceedings requiring drug testing.
The detectability of specific substances in the human body plays a crucial role in various fields, including employment, sports, and forensic science. Historically, drug testing focused on commonly abused substances. However, the expanding use of pharmaceuticals necessitates broader testing panels. The ability to identify ketamine use is essential in scenarios where impairment could pose a risk or in cases where adherence to prescribed treatment is being monitored.